Free Access
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 59 - 65
Published online 07 November 2018
  1. Perna FM, Dwyer LA, Tesauro G, et al. Research on Skin Cancer-Related Behaviors and Outcomes in the NIH Grant Portfolio, 2000–2014: Skin Cancer Intervention Across the Cancer Control Continuum (SCI-3C). JAMA Dermatol 2017 ; 153 : 398–405. [CrossRef] [PubMed] [Google Scholar]
  2. The Surgeon General‘s Call to Action to Prevent Skin Cancer. Washington (DC)2014. [Google Scholar]
  3. Luke JJ, Triozzi PL, McKenna KC, et al. Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res 2015 ; 28 : 135–147. [CrossRef] [Google Scholar]
  4. Corrie P, Hategan M, Fife K, Parkinson C. Management of melanoma. Br Med Bull 2014 ; 111 : 149–162. [CrossRef] [PubMed] [Google Scholar]
  5. Situm M, Buljan M, Kolic M, Vucic M. Melanoma–clinical, dermatoscopical, and histopathological morphological characteristics. Acta Dermatovenerol Croat 2014 ; 22 : 1–12. [PubMed] [Google Scholar]
  6. Jaimes N, Marghoob AA. The morphologic universe of melanoma. Dermatol Clin 2013; 31 : 599–613, viii-ix. [CrossRef] [PubMed] [Google Scholar]
  7. Dao AH, Page DL, Reynolds VH, Adkins RB, Jr.. Primary malignant melanoma of the adrenal gland. A report of two cases and review of the literature. Am Surg 1990 ; 56 : 199–203. [Google Scholar]
  8. Marchi S, Pinton P. Mitochondrial calcium uniporter, MiRNA and cancer: Live and let die. Commun Integr Biol 2013 ; 6 : e23818. [CrossRef] [PubMed] [Google Scholar]
  9. Zhang H, Zuo Z, Lu X, et al. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep 2012 ; 27 : 594–598. [PubMed] [Google Scholar]
  10. Gong J, Cui Z, Li L, et al. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7. Tumour Biol 2015 ; 36 : 7831–7840. [CrossRef] [PubMed] [Google Scholar]
  11. Wang C, Wang X, Su Z, et al. MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1. Oncotarget 2015 ; 6 : 36231–36244. [PubMed] [Google Scholar]
  12. Xiang J, Hang JB, Che JM, Li HC. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7. Int J Clin Exp Pathol 2015 ; 8 : 9147–9153. [PubMed] [Google Scholar]
  13. Huo J, Zhang Y, Li R, et al. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/beta-Catenin Pathway. Int J Mol Sci 2016 ; 17 : [Google Scholar]
  14. Wu X, Zhou H, Yue B, et al. Upregulation of microRNA-25-3p inhibits proliferation, migration and invasion of osteosarcoma cells in vitro by directly targeting SOX4. Mol Med Rep 2017 ; 16 : 4293–4300. [CrossRef] [PubMed] [Google Scholar]
  15. Feng X, Jiang J, Shi S, et al. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Int J Oncol 2016 ; 49 : 2600–2610. [CrossRef] [PubMed] [Google Scholar]
  16. Zhang Y, Peng Z, Zhao Y, Chen L. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC. Med Sci Monit 2016 ; 22 : 1415–1420. [CrossRef] [PubMed] [Google Scholar]
  17. Zhang JF, Shi LL, Zhang L, et al. MicroRNA-25 Negatively Regulates Cerebral Ischemia/Reperfusion Injury-Induced Cell Apoptosis Through Fas/FasL Pathway. J Mol Neurosci 2016 ; 58 : 507–516. [CrossRef] [PubMed] [Google Scholar]
  18. Chen Z, Wu Y, Meng Q, Xia Z. Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3. In Vitro Cell Dev Biol Anim 2016 ; 52 : 62–67. [CrossRef] [PubMed] [Google Scholar]
  19. Guan R, El-Rass S, Spillane D, et al. rbm47, a novel RNA binding protein, regulates zebrafish head development. Dev Dyn 2013 ; 242 : 1395–1404. [CrossRef] [PubMed] [Google Scholar]
  20. Yeganeh M, Seyedjafari E, Kamrani FA, Ghaemi N. RNA-binding protein Rbm47 binds to Nanog in mouse embryonic stem cells. Mol Biol Rep 2013 ; 40 : 4391–4396. [CrossRef] [PubMed] [Google Scholar]
  21. Cieply B, Park JW, Nakauka-Ddamba A, et al. Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins. Cell Rep 2016 ; 15 : 247–255. [CrossRef] [PubMed] [Google Scholar]
  22. Rokavec M, Kaller M, Horst D, Hermeking H. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Sci Rep 2017 ; 7 : 4687. [CrossRef] [PubMed] [Google Scholar]
  23. Vanharanta S, Marney CB, Shu W, et al. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. Elife 2014; 3. [CrossRef] [Google Scholar]
  24. Yang Y, Park JW, Bebee TW, et al. Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition. Mol Cell Biol 2016 ; 36 : 1704–1719. [CrossRef] [PubMed] [Google Scholar]
  25. Sakurai T, Isogaya K, Sakai S, et al. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma. Oncogene 2016 ; 35 : 5000–5009. [CrossRef] [Google Scholar]
  26. Wahlquist C, Jeong D, Rojas-Munoz A, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature 2014 ; 508 : 531–535. [CrossRef] [PubMed] [Google Scholar]
  27. Marchi S, Lupini L, Patergnani S, et al. Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25. Curr Biol 2013 ; 23 : 58–63. [CrossRef] [PubMed] [Google Scholar]
  28. Razumilava N, Bronk SF, Smoot RL, et al. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2012 ; 55 : 465–475. [CrossRef] [PubMed] [Google Scholar]
  29. Espinosa-Parrilla Y, Munoz X, Bonet C, et al. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. Int J Cancer 2014 ; 135 : 2065–2076. [CrossRef] [PubMed] [Google Scholar]
  30. Zhang R, Wang W, Li F, et al. MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med Oncol 2014 ; 31 : 243. [CrossRef] [PubMed] [Google Scholar]
  31. Qi L, Zhi J, Zhang T, et al. Inhibition of microRNA-25 by tumor necrosis factor alpha is critical in the modulation of vascular smooth muscle cell proliferation. Mol Med Rep 2015 ; 11 : 4353–4358. [CrossRef] [PubMed] [Google Scholar]
  32. Wang XH, Cai P, Wang MH, Wang Z. microRNA25 promotes osteosarcoma cell proliferation by targeting the cellcycle inhibitor p27. Mol Med Rep 2014 ; 10 : 855–859. [CrossRef] [PubMed] [Google Scholar]
  33. Fossat N, Tourle K, Radziewic T, et al. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. EMBO Rep 2014 ; 15 : 903–910. [CrossRef] [PubMed] [Google Scholar]
  34. Rayon-Estrada V, Harjanto D, Hamilton CE, et al. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function. Proc Natl Acad Sci USA 2017 ; 114 : 13296–13301. [CrossRef] [Google Scholar]
  35. Fossat N, Tam PP. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing. RNA Biol 2014; 11 : 1233–7. [CrossRef] [Google Scholar]
  36. Severi F, Conticello SG. Flow-cytometric visualization of C>U mRNA editing reveals the dynamics of the process in live cells. RNA Biol 2015 ; 12 : 389–397. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.